For richer, for poorer, in sickness and in health: The entanglement of science and marketing
Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical indus...
Gespeichert in:
Veröffentlicht in: | Australian and New Zealand journal of psychiatry 2012-06, Vol.46 (6), p.498-500 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 500 |
---|---|
container_issue | 6 |
container_start_page | 498 |
container_title | Australian and New Zealand journal of psychiatry |
container_volume | 46 |
creator | Smith, Geoffrey P |
description | Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence. |
doi_str_mv | 10.1177/0004867412446492 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1019617894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0004867412446492</sage_id><sourcerecordid>1019617894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</originalsourceid><addsrcrecordid>eNp1kL1PwzAQxS0EoqWwM6FILAwE_BV_sKGKAhISS9mQIje5NGlTp9iJBPz1OKQwILH4nX2_ez49hE4JviJEymuMMVdCckI5F1zTPTQmnOOYCML30bhvx31_hI68X2FMGEnkIRpRKqSmmI7R66xxkauyEtxlVIR62zSurysb-SpbW_A-Mjbv7yWYui1vonkJEdjW2GUNm1BETRH5rAKbwTe6MW4NbWWXx-igMLWHk51O0Mvsbj59iJ-e7x-nt09xxkTSxloYnAujQUmTELzQCjDRKkh41EqEpXnBEgGZEHzBGAYhDFNMyYRQ4DmboIvBd-uatw58m24qn0FdGwtN51MS7ASRSvOA4gHNXOO9gyLduios_BGgtM80_ZtpGDnbuXeLDeS_Az8hBuB8AGxtP9PK5vAeVGvJEk4VEzgcMlDxQHmzhHTVdM6GTP7_9gvOHYay</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1019617894</pqid></control><display><type>article</type><title>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Smith, Geoffrey P</creator><creatorcontrib>Smith, Geoffrey P</creatorcontrib><description>Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><identifier>ISSN: 0004-8674</identifier><identifier>EISSN: 1440-1614</identifier><identifier>DOI: 10.1177/0004867412446492</identifier><identifier>PMID: 22679202</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Australia ; Bias ; Conflict of Interest ; Conflict of interests ; Drug Industry - economics ; Drug Industry - ethics ; Drug Industry - standards ; Drugs ; Ethics, Research ; Finance ; Humans ; Interprofessional Relations - ethics ; Marketing ; Marketing - ethics ; Medicine ; Moral and ethical aspects ; Pharmaceutical ethics ; Professional ethics ; Psychiatrists ; Psychiatry - ethics ; Research Support as Topic - ethics</subject><ispartof>Australian and New Zealand journal of psychiatry, 2012-06, Vol.46 (6), p.498-500</ispartof><rights>The Royal Australian and New Zealand College of Psychiatrists 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</citedby><cites>FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0004867412446492$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0004867412446492$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21817,27922,27923,43619,43620</link.rule.ids><backlink>$$Uhttps://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,997354283602837&tab=innz&search_scope=INNZ&vid=NLNZ&offset=0$$DView this record in NLNZ$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22679202$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smith, Geoffrey P</creatorcontrib><title>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</title><title>Australian and New Zealand journal of psychiatry</title><addtitle>Aust N Z J Psychiatry</addtitle><description>Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</description><subject>Australia</subject><subject>Bias</subject><subject>Conflict of Interest</subject><subject>Conflict of interests</subject><subject>Drug Industry - economics</subject><subject>Drug Industry - ethics</subject><subject>Drug Industry - standards</subject><subject>Drugs</subject><subject>Ethics, Research</subject><subject>Finance</subject><subject>Humans</subject><subject>Interprofessional Relations - ethics</subject><subject>Marketing</subject><subject>Marketing - ethics</subject><subject>Medicine</subject><subject>Moral and ethical aspects</subject><subject>Pharmaceutical ethics</subject><subject>Professional ethics</subject><subject>Psychiatrists</subject><subject>Psychiatry - ethics</subject><subject>Research Support as Topic - ethics</subject><issn>0004-8674</issn><issn>1440-1614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1PwzAQxS0EoqWwM6FILAwE_BV_sKGKAhISS9mQIje5NGlTp9iJBPz1OKQwILH4nX2_ez49hE4JviJEymuMMVdCckI5F1zTPTQmnOOYCML30bhvx31_hI68X2FMGEnkIRpRKqSmmI7R66xxkauyEtxlVIR62zSurysb-SpbW_A-Mjbv7yWYui1vonkJEdjW2GUNm1BETRH5rAKbwTe6MW4NbWWXx-igMLWHk51O0Mvsbj59iJ-e7x-nt09xxkTSxloYnAujQUmTELzQCjDRKkh41EqEpXnBEgGZEHzBGAYhDFNMyYRQ4DmboIvBd-uatw58m24qn0FdGwtN51MS7ASRSvOA4gHNXOO9gyLduios_BGgtM80_ZtpGDnbuXeLDeS_Az8hBuB8AGxtP9PK5vAeVGvJEk4VEzgcMlDxQHmzhHTVdM6GTP7_9gvOHYay</recordid><startdate>201206</startdate><enddate>201206</enddate><creator>Smith, Geoffrey P</creator><general>SAGE Publications</general><scope>DUNLO</scope><scope>GOM</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201206</creationdate><title>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</title><author>Smith, Geoffrey P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-96a0d6a9e87a510b98e019898e6a99863154f356ec664b330e66a38387512e4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Australia</topic><topic>Bias</topic><topic>Conflict of Interest</topic><topic>Conflict of interests</topic><topic>Drug Industry - economics</topic><topic>Drug Industry - ethics</topic><topic>Drug Industry - standards</topic><topic>Drugs</topic><topic>Ethics, Research</topic><topic>Finance</topic><topic>Humans</topic><topic>Interprofessional Relations - ethics</topic><topic>Marketing</topic><topic>Marketing - ethics</topic><topic>Medicine</topic><topic>Moral and ethical aspects</topic><topic>Pharmaceutical ethics</topic><topic>Professional ethics</topic><topic>Psychiatrists</topic><topic>Psychiatry - ethics</topic><topic>Research Support as Topic - ethics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smith, Geoffrey P</creatorcontrib><collection>Index New Zealand (A&I)</collection><collection>Index New Zealand</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Australian and New Zealand journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smith, Geoffrey P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>For richer, for poorer, in sickness and in health: The entanglement of science and marketing</atitle><jtitle>Australian and New Zealand journal of psychiatry</jtitle><addtitle>Aust N Z J Psychiatry</addtitle><date>2012-06</date><risdate>2012</risdate><volume>46</volume><issue>6</issue><spage>498</spage><epage>500</epage><pages>498-500</pages><issn>0004-8674</issn><eissn>1440-1614</eissn><abstract>Examines the case of a review of the antidepressant agomelatine by Professor Ian Hickie and Associate Professor Naomi Rogers (Brain and Mind Institute) for the issues it raises about the contemporary practice in the reporting of conflicts of interest. Looks at the control of the pharmaceutical industry over the evaluation of its products, its use of opinion leaders, and its accountability to shareholders. Calls for changes to the funding of medical research. Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons Attribution 3.0 New Zealand Licence.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>22679202</pmid><doi>10.1177/0004867412446492</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0004-8674 |
ispartof | Australian and New Zealand journal of psychiatry, 2012-06, Vol.46 (6), p.498-500 |
issn | 0004-8674 1440-1614 |
language | eng |
recordid | cdi_proquest_miscellaneous_1019617894 |
source | MEDLINE; SAGE Complete A-Z List |
subjects | Australia Bias Conflict of Interest Conflict of interests Drug Industry - economics Drug Industry - ethics Drug Industry - standards Drugs Ethics, Research Finance Humans Interprofessional Relations - ethics Marketing Marketing - ethics Medicine Moral and ethical aspects Pharmaceutical ethics Professional ethics Psychiatrists Psychiatry - ethics Research Support as Topic - ethics |
title | For richer, for poorer, in sickness and in health: The entanglement of science and marketing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T16%3A17%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=For%20richer,%20for%20poorer,%20in%20sickness%20and%20in%20health:%20The%20entanglement%20of%20science%20and%20marketing&rft.jtitle=Australian%20and%20New%20Zealand%20journal%20of%20psychiatry&rft.au=Smith,%20Geoffrey%20P&rft.date=2012-06&rft.volume=46&rft.issue=6&rft.spage=498&rft.epage=500&rft.pages=498-500&rft.issn=0004-8674&rft.eissn=1440-1614&rft_id=info:doi/10.1177/0004867412446492&rft_dat=%3Cproquest_cross%3E1019617894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1019617894&rft_id=info:pmid/22679202&rft_sage_id=10.1177_0004867412446492&rfr_iscdi=true |